Devika Desai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Devika Desai has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Glen C. Ulett
School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Queensland, Australia
3 shared publications - Guan Kai Kelvin Goh
Institute for Biomedicine and Glycomics, Griffith University, Gold Coast Campus, Southport 4222, QLD, Australia
3 shared publications - Matthew J. Sullivan
School of Biological Sciences, University of East Anglia, Norwich, NR4 7TJ, UK
3 shared publications - Ellen Copeman
School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, UK
2 shared publications - Deepak Samuel Ipe
School of Pharmacy and Medical Sciences, Institute for Biomedicine and Glycomics, Griffith University, Gold Coast Campus, Gold Coast, QLD 4222, Australia
1 shared publication - Dhruba Acharya
School of Pharmacy and Medical Sciences and Menzies Health Institute Queensland, Griffith University, Gold Coast Campus, QLD 4222, Australia
1 shared publication
Latest Publications
- Open Access
- 19 March 2025
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 74 (3) , 001975
Multidrug resistance in group B Streptococcus causing urinary tract infection exposes an erythromycin-driven protective effect against oxidative stress
Multidrug resistance has been reported in group B Streptococcus (GBS) from various origins, but rates among urinary tract infection (UTI) isolates are largely unknown. Erythromycin, a second-line antibiotic for GBS for which high rates of resistance have been reported, was recently shown to support the resistance of Staphylococcus to oxidative stress. To survey multidrug-resistant (MDR) GBS from UTI and to investigate the effect of erythromycin exposure on the bacteria’s ability to resist oxidative stress, we determined the antibacterial activity of 18 antibiotics against 292 GBS UTI isolates by disc diffusion and used in vitro growth assays of MDR GBS exposed to erythromycin to examine relative resistance to oxidative stress in the form of H2O2. A high proportion of all 292 GBS isolates (33.6%) were MDR, reflecting high rates of resistance to four antibiotics: azithromycin (44.5%), clindamycin (26%), erythromycin (36.3%) and tetracycline (81.5%); however, no resistance was detected for any other antibiotics tested. Rates of resistance were not significantly different when analysed according to clinical origins (acute and recurrent UTI, asymptomatic bacteriuria). The growth of MDR GBS was attenuated and severely inhibited by exposure to erythromycin and H2O2, respectively. Surprisingly, exposure of MDR GBS to erythromycin significantly relieved the severe growth inhibitory effect of H2O2, signifying a partial rescue effect of the antibiotic. The GBS isolates in this study exhibit high levels of multidrug resistance without an association between resistance and clinical origin. Exposure of MDR GBS to erythromycin can partially counteract the severe growth inhibitory effect from H2O2.
- 19 March 2025
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 74 (3) , 001975
Open AccessMultidrug resistance in group B Streptococcus causing urinary tract infection exposes an erythromycin-driven protective effect against oxidative stress
Multidrug resistance has been reported in group B Streptococcus (GBS) from various origins, but rates among urinary tract infection (UTI) isolates are largely unknown. Erythromycin, a second-line antibiotic for GBS for which high rates of resistance have been reported, was recently shown to support the resistance of Staphylococcus to oxidative stress. To survey multidrug-resistant (MDR) GBS from UTI and to investigate the effect of erythromycin exposure on the bacteria’s ability to resist oxidative stress, we determined the antibacterial activity of 18 antibiotics against 292 GBS UTI isolates by disc diffusion and used in vitro growth assays of MDR GBS exposed to erythromycin to examine relative resistance to oxidative stress in the form of H2O2. A high proportion of all 292 GBS isolates (33.6%) were MDR, reflecting high rates of resistance to four antibiotics: azithromycin (44.5%), clindamycin (26%), erythromycin (36.3%) and tetracycline (81.5%); however, no resistance was detected for any other antibiotics tested. Rates of resistance were not significantly different when analysed according to clinical origins (acute and recurrent UTI, asymptomatic bacteriuria). The growth of MDR GBS was attenuated and severely inhibited by exposure to erythromycin and H2O2, respectively. Surprisingly, exposure of MDR GBS to erythromycin significantly relieved the severe growth inhibitory effect of H2O2, signifying a partial rescue effect of the antibiotic. The GBS isolates in this study exhibit high levels of multidrug resistance without an association between resistance and clinical origin. Exposure of MDR GBS to erythromycin can partially counteract the severe growth inhibitory effect from H2O2.
- Open Access
- 20 February 2025
- Published by Microbiology Society in Microbiology
- Vol. 171 (2) , 001533
Group B Streptococcus growth in human urine is associated with asymptomatic bacteriuria rather than urinary tract infection and is unaffected by iron sequestration
Group B Streptococcus (GBS) causes various infections in adults, including urinary tract infection (UTI) and asymptomatic bacteriuria (ABU). Some bacteria that cause ABU can utilize urine as a substrate for growth, which can promote asymptomatic colonization in the host. An analysis of diverse GBS isolates associated with ABU and UTI for growth in human urine has not been undertaken. Here, we examined a large collection of clinical urinary GBS isolates from individuals with acute UTI (n=62), and ABU with bacteriuria ≥104 c.f.u. ml−1 (n=206) or 4 c.f.u. ml−1 (n=90) for their ability to grow in human urine. Among all 358 GBS isolates analysed, 40 exhibited robust growth in urine in contrast to 25 that were unable to grow and non-culturable after incubation in urine. Growth phenotypes were disproportionately represented among the different groups of isolates, whereby robust growth was significantly more likely to be associated with high-grade ABU versus low-grade ABU or acute UTI (38/40 vs. 11/25; odds ratio 4.6, 95% CI, 1.5–14.8). Growth of bacteria in urine can depend on iron bioavailability, and we therefore performed growth assays using urine supplemented with 2,2-dipyridyl to chelate iron. In contrast to a control strain of ABU Escherichia coli, for which iron limitation significantly attenuated growth, iron sequestration had no significant attenuation effect on the growth of ABU GBS strain 834 in urine. Despite this finding, PCR confirmed the presence of several known growth-associated genes in GBS 834, including fhuD for iron uptake. We conclude that GBS adaptation for growth in human urine is more likely to be associated with high-grade ABU than acute UTI, and for GBS 834, this growth trait is not significantly constrained by conditions of iron sequestration.
- 20 February 2025
- Published by Microbiology Society in Microbiology
- Vol. 171 (2) , 001533
Open AccessGroup B Streptococcus growth in human urine is associated with asymptomatic bacteriuria rather than urinary tract infection and is unaffected by iron sequestration
Group B Streptococcus (GBS) causes various infections in adults, including urinary tract infection (UTI) and asymptomatic bacteriuria (ABU). Some bacteria that cause ABU can utilize urine as a substrate for growth, which can promote asymptomatic colonization in the host. An analysis of diverse GBS isolates associated with ABU and UTI for growth in human urine has not been undertaken. Here, we examined a large collection of clinical urinary GBS isolates from individuals with acute UTI (n=62), and ABU with bacteriuria ≥104 c.f.u. ml−1 (n=206) or 4 c.f.u. ml−1 (n=90) for their ability to grow in human urine. Among all 358 GBS isolates analysed, 40 exhibited robust growth in urine in contrast to 25 that were unable to grow and non-culturable after incubation in urine. Growth phenotypes were disproportionately represented among the different groups of isolates, whereby robust growth was significantly more likely to be associated with high-grade ABU versus low-grade ABU or acute UTI (38/40 vs. 11/25; odds ratio 4.6, 95% CI, 1.5–14.8). Growth of bacteria in urine can depend on iron bioavailability, and we therefore performed growth assays using urine supplemented with 2,2-dipyridyl to chelate iron. In contrast to a control strain of ABU Escherichia coli, for which iron limitation significantly attenuated growth, iron sequestration had no significant attenuation effect on the growth of ABU GBS strain 834 in urine. Despite this finding, PCR confirmed the presence of several known growth-associated genes in GBS 834, including fhuD for iron uptake. We conclude that GBS adaptation for growth in human urine is more likely to be associated with high-grade ABU than acute UTI, and for GBS 834, this growth trait is not significantly constrained by conditions of iron sequestration.
- Open Access
- 24 April 2024
- Published by Microbiology Society in Microbiology
- Vol. 170 (4) , 001453
Alterations in cell arrangements of group B streptococcus due to virulence factor expression can bias estimates of bacterial populations based on colony count measures
Group B streptococcus (GBS) is a chain-forming commensal bacterium and opportunistic pathogen that resides in the gastrointestinal and genitourinary tract of healthy adults. GBS can cause various infections and related complications in pregnant and nonpregnant women, adults, and newborns. Investigations of the mechanisms by which GBS causes disease pathogenesis often utilize colony count assays to estimate bacterial population size in experimental models. In other streptococci, such as group A streptococcus and pneumococcus, variation in the chain length of the bacteria that can occur naturally or due to mutation can affect facets of pathogenesis, such as adherence to or colonization of a host. No studies have reported a relationship between GBS chain length and pathogenicity. Here, we used GBS strain 874391 and several derivative strains displaying longer chain-forming phenotypes (874391pgapC, 874391ΔcovR, 874391Δstp1) to assess the impact of chain length on bacterial population estimates based on the colony-forming unit (c.f.u.) assay. Disruption of GBS chains via bead beating or sonication in conjunction with fluorescence microscopy was used to compare chaining phenotypes pre- and post-disruption to detect long- and short-chain forms, respectively. We used a murine model of GBS colonization of the female reproductive tract to assess whether chaining may affect bacterial colonization dynamics in the host during chronic infection in vivo. Overall, we found that GBS exhibiting long-chain form can significantly affect population size estimates based on the colony count assay. Additionally, we found that the length of chaining of GBS can affect virulence in the reproductive tract colonization model. Collectively, these findings have implications for studies of GBS that utilize colony count assays to measure GBS populations and establish that chain length can affect infection dynamics and disease pathogenesis for this important opportunistic pathogen.
- 24 April 2024
- Published by Microbiology Society in Microbiology
- Vol. 170 (4) , 001453
Open AccessAlterations in cell arrangements of group B streptococcus due to virulence factor expression can bias estimates of bacterial populations based on colony count measures
Group B streptococcus (GBS) is a chain-forming commensal bacterium and opportunistic pathogen that resides in the gastrointestinal and genitourinary tract of healthy adults. GBS can cause various infections and related complications in pregnant and nonpregnant women, adults, and newborns. Investigations of the mechanisms by which GBS causes disease pathogenesis often utilize colony count assays to estimate bacterial population size in experimental models. In other streptococci, such as group A streptococcus and pneumococcus, variation in the chain length of the bacteria that can occur naturally or due to mutation can affect facets of pathogenesis, such as adherence to or colonization of a host. No studies have reported a relationship between GBS chain length and pathogenicity. Here, we used GBS strain 874391 and several derivative strains displaying longer chain-forming phenotypes (874391pgapC, 874391ΔcovR, 874391Δstp1) to assess the impact of chain length on bacterial population estimates based on the colony-forming unit (c.f.u.) assay. Disruption of GBS chains via bead beating or sonication in conjunction with fluorescence microscopy was used to compare chaining phenotypes pre- and post-disruption to detect long- and short-chain forms, respectively. We used a murine model of GBS colonization of the female reproductive tract to assess whether chaining may affect bacterial colonization dynamics in the host during chronic infection in vivo. Overall, we found that GBS exhibiting long-chain form can significantly affect population size estimates based on the colony count assay. Additionally, we found that the length of chaining of GBS can affect virulence in the reproductive tract colonization model. Collectively, these findings have implications for studies of GBS that utilize colony count assays to measure GBS populations and establish that chain length can affect infection dynamics and disease pathogenesis for this important opportunistic pathogen.